Liu, Y.; Dong, C.; He, X.; Shu, Y.; Wu, P.; Zou, J. Post-Marketing Safety of Vemurafenib: A Real-World Pharmacovigilance Study of the FDA Adverse Event Reporting System. J Pharm Pharm Sci 2022, 25, 377-390.